Showing posts with label Dr Scholl's. Show all posts
Showing posts with label Dr Scholl's. Show all posts

Tuesday, October 21, 2008

GDNF REVISITED - Glial Cell Derived Neurotrophic Factor for PD

GDNF anf Parkinson's Disease

GDNF is a protein that helps brain cells grow and protects them from death. It was developed by biotech firm Synergen. Amgen bought Synergen in Dec 1994 for $240 million dollars. Amgen thought they could use GDNF to grow new dopamine-producing cells to slow the progression or stop Parkinson's disease.

GDNF, glial cell derived neurotrophic factor, does not travel through the brain blood barrier so it can't just be given as a pill or an injection, it has to be placed directly in the area of the brain where it is needed.

Dr. Steven Gill at Frenchay Hospital in Bristol, England designed a system using two abdomen pumps, two holes drilled through the skull and two narrow catheters to deliver the drug to the brain. All five patients receiving the treatment showed improvement. In another group of patients at the University of Kentucky all ten showed improvement. All of these patients knew they were getting the drug so a placebo effect was possible.

Phase II compensated for the placebo effect by enrolling 34 patients, half received GNDF and half saline solution. The results were mixed, some patients on saline did as well as those who got GDNF. A few patients developed antibodies to GDNF. Amgen stopped the tests in September 2004 amid controversy. Some patients had improved greatly and wanted Amgen to continue making GDNF available to them as a compassionate use, but the company refused. There were court cases but Amgen won every case.

In Sept 2008 Amsterdam Molecular Therapeutics (AMT) licensed the right from Amgen to use their GDNF gene and AMT's gene therapy platform to develop a new gene therapy treatment for Parkinson's disease.

AMT will use its adeno-associated virus (AAV) technology in the assessment of the gene’s potential to protect and enhance the function of the nerve cells that produce dopamine. If they are successful in a few years it may be possible to inject a benigin virus under the skin or in a muscle that will stop the progression or cure Parkinson's Disease.

Sources:
New York Times ,7/18/1994
Medical News Today, 9/27/2008
Andrew Pollack, New York Times 11/26/2004
Parkinson's Med,Sept 13,2008
Science News 2003

Monday, September 8, 2008

Massage Therapy and PD

Keeping my Parkinson's disease progression as slow as possible


I've had Parkinson's disease for 5+ years now. I've been trying to avoid taking levodopa because of its possible side effects that often start after 5 years of increasing dosage. Medications I now take are azilect, COQ10, and isradipine for PD. They eliminate or reduce my symptoms of tremor, soft voice and foot drop, while leaving me with slowly progressing muscular rigidity, gait difficulty and slowness of movement.

Seven months ago I began massage therapy for arthritis in my knees because I had read about positive results in a Yale University study for the CDC. The study showed that Swedish massage therapy reduced pain while improving flexibility and range of motion in arthritis patients.

I've been getting a one hour massage every week and the pain in my knees is mostly gone, unless I lift heavy things or wear shoes that are not soft, flexible and low heeled. In recent months I've been wearing Dr Scholl's Lara medium or wide width with the gel insole. Yes, I am gellin' and it seems to help my comfort level.

Most large metro areas will have lots of Massage Therapists. Find one who is familiar with Arthritis and Parkinson's and is listed by the American Massage Therapy Association. Most will offer several different styles of massage. Each of us is different, but Swedish massage has tested as pain relieving for arthritis.

In a small study conducted by Touch Research Institute at the University of Miami 16 adults diagnosed with Parkinson's disease were randomly assigned to either progressive muscle relaxation exercise or massage for 30 minutes twice a week.

The results were that those in the massage group had improvements in daily functioning and urine tests showed a reduction in stress hormone norepinephrine and the massage group had fewer sleep disturbances.

I will discuss my own massage therapy in more detail in an upcoming Parkinson's Focus Today post.